天然产物研究与开发 ›› 2015, Vol. 27 ›› Issue (3): 517-520.doi: 10.16333/j.1001-6880.2015.03.030

• 开发研究 • 上一篇    下一篇

骆驼刺提取物体内外抗肿瘤作用及机制初探

马晓玲,魏鸿雁*,徐晓琴,夏提古丽·阿不力孜   

  1. 新疆维吾尔自治区中药民族药研究所,乌鲁木齐 830002
  • 出版日期:2015-03-30 发布日期:2015-04-07

Antitumor Activity of Alhagi sparsifolia Shap (L.) Extract in vivo and in vitro

MA Xiao-ling,WEI Hong-yan*,XU Xiao-qin,XIATIGULI Abulizi   

  1. Xinjiang Institute of Chinese Medicine and Medicine of National,Urumqi 830002,China
  • Online:2015-03-30 Published:2015-04-07

摘要: 为了探讨骆驼刺提取物在体内外对肿瘤细胞增殖的抑制作用,应用MTT法考察骆驼刺提取物在体外对人胃癌BGC-823、人食道癌Eca-109、人结肠癌HT-29和人肝癌HepG2细胞株的抑制作用。为明确其体内抗肿瘤疗效,建立CT26结肠癌小鼠模型,通过比较各组小鼠的肿瘤增殖率、生长曲线和抑瘤率等指标考察体内抑瘤效果。结果表明骆驼刺提取物对HepG2和HT-29的IC50值小于1.5 mg/mL,在体内的抗肿瘤药效实验中仅高剂量组表现出明显的抗肿瘤活性。证明骆驼刺提取物对HepG2和HT29表现出明显的体外抑瘤作用,对CT26结肠癌实体瘤模型有一定敏感性。

关键词: 骆驼刺, 抗肿瘤, 结肠癌, 抑瘤率

Abstract: To investigate the antitumor activities of Alhagi sparsifolia shap.extract,cell proliferation was determined using methyl thiazolyl tetrazohum (MTT) assay.BGC823,Eca-109,HT-29 and HepG2 cancer cells were incubated in culture media containing Alhagi sparsifolia shap.extract.In order to determine the in vivo antitumor effect of A.sparsifolia extract,the CT26 colon cancer mice model was established.By comparing the relative tumor proliferation rate,growth curves,inhibition rate of different groups,the antitumor effect was evaluated.In the MTT assay, A.sparsifolia extract showed obvious antitumor effect on HepG2 and HT-29 cells.In the in vivo experiment, A.sparsifolia extract also exhibited significant antitumor effect.These results demonstrated that  A.sparsifolia extract can inhibit the tumor of CT26 in mice,the drug had obvious anticancer effects against HepG2 and HT-29.

Key words: Alhagi sparsifolia shap., antitumor, colon cancer, inhibition rate

中图分类号: 

R285.5